Capital Fund Management (CFM)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-126,400
Closed -$12.6M 2120
2019
Q3
$12.6M Sell
126,400
-48,000
-28% -$4.56M 0.11% 245
2019
Q2
$16.1M Sell
174,400
-247,200
-59% -$23.5M 0.15% 201
2019
Q1
$39.8M Sell
421,600
-165,900
-28% -$14.5M 0.36% 49
2018
Q4
$37.7M Buy
587,500
+65,900
+13% +$4.86M 0.33% 54
2018
Q3
$46.7M Sell
521,600
-525,800
-50% -$46.5M 0.25% 75
2018
Q2
$83.2M Buy
1,047,400
+183,200
+21% +$15.2M 0.43% 25
2018
Q1
$77.1M Buy
864,200
+409,700
+90% +$39.3M 0.46% 21
2017
Q4
$47.4M Buy
454,500
+343,300
+309% +$38.7M 0.26% 95
2017
Q3
$16.2M Buy
111,200
+68,100
+158% +$9.28M 0.12% 221
2017
Q2
$5.6M Buy
43,100
+19,000
+79% +$2.33M 0.05% 440
2017
Q1
$3M Sell
24,100
-211,300
-90% -$25.3M 0.03% 626
2016
Q4
$27.2M Buy
235,400
+230,800
+5,017% +$25.7M 0.23% 113
2016
Q3
$481K Sell
4,600
-112,900
-96% -$12.2M ﹤0.01% 1217
2016
Q2
$11.6M Sell
117,500
-122,000
-51% -$12.6M 0.11% 225
2016
Q1
$24M Buy
239,500
+188,400
+369% +$19.4M 0.23% 106
2015
Q4
$6.12M Sell
51,100
-7,500
-13% -$868K 0.06% 394
2015
Q3
$6.34M Sell
58,600
-43,800
-43% -$5.44M 0.07% 344
2015
Q2
$11.9M Buy
102,400
+10,700
+12% +$1.22M 0.15% 183
2015
Q1
$10.6M Sell
91,700
-247,500
-73% -$29.6M 0.14% 188
2014
Q4
$37.9M Sell
339,200
-91,200
-21% -$9.62M 0.45% 40
2014
Q3
$40.8M Sell
430,400
-144,200
-25% -$13M 0.46% 33
2014
Q2
$49.3M Buy
574,600
+424,400
+283% +$32.3M 0.52% 17
2014
Q1
$10.5M Sell
150,200
-29,200
-16% -$2.31M 0.13% 187
2013
Q4
$15.2M Sell
179,400
-213,000
-54% -$16.9M 0.19% 99
2013
Q3
$30.2M Buy
392,400
+373,800
+2,010% +$26.2M 0.42% 37
2013
Q2
$1.09M Buy
+18,600
New +$1.12M 0.02% 788

Other funds holding CELG

Capital Fund Management (CFM)'s CELG Position: Q1 2019 in Review

Capital Fund Management (CFM) sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 197,750 shares — an estimated $17.3M sold.

Capital Fund Management (CFM) first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $42.5M in Q2 2016. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Capital Fund Management (CFM) reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 197,750 Celgene Corp shares in Q1 2019, an estimated $17.3M.
  • Capital Fund Management (CFM) first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Celgene Corp position peaked at $42.5M in Q2 2016.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2019, filed 13 May 2019.